Advertisement

Topics

ABAC Therapeutics raises 16 million euros from investors including Debiopharm

10:01 EST 15 Feb 2018 | thePharmaLetter

Spain-based ABAC Therapeutics, a leader in pathogen-specific antibiotics, announced today the closing…

Original Article: ABAC Therapeutics raises 16 million euros from investors including Debiopharm

NEXT ARTICLE

More From BioPortfolio on "ABAC Therapeutics raises 16 million euros from investors including Debiopharm"

Advertisement
Quick Search
Advertisement
Advertisement